Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Br J Haematol. 2011 Nov 25;156(3):388–401. doi: 10.1111/j.1365-2141.2011.08952.x

Table I.

Demographic and other characteristics of Baseline Retrovirus Epidemiology Donor Study-II (REDS-II) donor Iron Status Evaluation (RISE) donors (n=2,425)

N (%)
Race/Ethnicity
 Asian 76 (3.1)
 Black 116 (4.8)
 Hispanic 76 (3.1)
 White 2,111 (87.1)
 Other 29 (1.2)
 Missing 17 (0.7)
Gender
 Female 1,250 (51.6)
 Male 1,175 (48.4)
Age (years)
 16 – 29 476 (19.6)
 30 – 39 340 (14.0)
 40 – 49 497 (20.5)
 50 – 59 626 (25.8)
 60+ 486 (20.0)
HFE genotype
 Wild Type 1,568 (64.7%)
 Heterozygous H63D 573 (23.6%
 Heterozygous C282Y 194 (8.0%)
 Homozygous H63D 39 (1.6%)
 Homozygous C282Y 7 (0.3%)
 Double Mutation 41 (1.7%)
 Missing 3 (0.1%)
Donor Status
 First-Time/Reactivated 888 (36.6)
 Frequent/Repeat 1,537 (63.4)
Weight (kg)
 < 68 595 (24.5)
 68 – 78 623 (25.7)
 79 – 90 531 (21.9)
 ≥ 91 659 (27.2)
 Missing 17 (0.7)
Smoking
 Current smoker 313 (12.9)
 Past/Non/Unknown 2,112 (87.1)
Iron Supplementation
 Iron Supplement 954 (39.3)
 No iron Supplement 1,471 (60.7)
Menstrual Cycle (females)
 Periods have stopped 585 (46.8)
 Still having periods 665 (53.2)
Pregnancy Status (females)
 Ever Pregnant 831 (66.5)
 Unknown pregnancy status 13 (1.0)
 Never pregnant 406 (32.5)
TF G277S Genotype
 Wild Type 2,107 (86.9)
 Hetero- or Homozygous 254 (10.5)
 Missing 64 (2.6)
Red Cell donations in previous 2 years
 First-Time/Reactivated Donors 888 (36.6)
 ≤ 3 donations 317 (13.1)
 4–9 donations 1,011 (41.7)
 10+ donations 209 (8.6)
Blood Centre
 A 436 (18.0)
 B 390 (16.1)
 C 376 (15.5)
 D 392 (16.2)
 E 415 (17.1)
 F 416 (17.2)